Results

Total Results: over 10,000 records

Showing results for "define".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - not appropriately targeting the remaining areas of uncertainty7 and emphasizes the need to clearly define
  2. effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
    January 01, 2018 - They may also help define quality standards and provide insight into operational considerations to
  3. www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cg/guidance-cg-cahps.pdf
    April 01, 2021 - This information is used in the first question on the survey to define “this provider” for the respondent
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
    August 01, 2012 - 1 Comparative Effectiveness Review Number 63 First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness Executive Summary Introduction Antipsychotic medications are used to treat and manage symptoms for several psychiatric disorders and are commonly categorized into tw…
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
    October 01, 2014 - Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer Technical Brief Disposition of Comments Report Research Review Title: Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer Draft review available for public comment from Februa…
  6. Slide 1 (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/marketing_evidence_evans.ppt
    September 13, 2006 - Slide 1 Marketing “evidence” to healthcare consumers: Applying social marketing to evidence about the harms and benefits of pharmaceuticals Presented by W. Douglas Evans, Ph.D. Lauren McCormack, Ph.D., M.S.P.H Presented at Agency for Healthcare Research and Quality Conference: Communicating Harms and Benefits of …
  7. digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
    January 01, 2017 - Individualized Drug Interaction Alerts - Final Report Individualized Drug Interaction Alerts Investigators: Daniel C. Malone, RPh, PhD, Principal Investigator Richard D. Boyce, PhD, Co-Investigator Philip Hansten, PharmD, Consultant John R. Horn, PharmD, Consultant Andrew Romero, PharmD, Consultan…
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/advanced-care-decision-aids_disposition-comments.pdf
    July 29, 2014 - Technical Brief 16 Disposition of Comments Report Technical Brief Disposition of Comments Report Research Review Title: Decision Aids for Advance Care Planning Draft review available for public comment from February 12, 2014 to March 11, 2014. Research Review Citation: Butler M, Ratner E, McCreedy …
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-disposition-comments.pdf
    December 21, 2023 - Disposition of Comments_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidy and Mortality: An Evidence Map Comparative Effectiveness Review Disposition of Comments Report Title: Social and Structural Determinants of Maternal Morbidity and Mortality: An Evid…
  10. digital.ahrq.gov/sites/default/files/docs/citation/r18hs018167-roberts-final-report-2013.pdf
    January 01, 2013 - Self-Management & Reminders with Technology: SMART Appraisal of an Integrated PHR - Final Report Title: Self-Management & Reminders with Technology: SMART Appraisal of an Integrated PHR Principal Investigator: Mark S. Roberts, MD, MPP Team Members: Gary Fischer MD, University of Pittsburgh, Co-Investigator …
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
    November 01, 2017 - Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary Comparative Effectiveness Review Number 193 Effective Health Care Program Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel Executive Summary Background…
  12. digital.ahrq.gov/sites/default/files/docs/publication/uc1hs014920-bellamy-final-report-2007.pdf
    January 01, 2007 - Partnering to Improve Patient Safety in Rural WV - Final Report Title of Project: Partnering to Improve Patient Safety in Rural West Virginia Hospitals Principal Investigator and Team Members Gail R. Bellamy, Ph.D., Principal Investigator …
  13. psnet.ahrq.gov/perspective/emergence-trigger-tool-premier-measurement-strategy-patient-safety
    May 01, 2012 - The Emergence of the Trigger Tool as the Premier Measurement Strategy for Patient Safety Paul J. Sharek, MD, MPH | May 1, 2012  Also Read a Conversation View more articles from the same authors. Citation Text: Sharek PJ. The Emergence of the Trigger Tool as the …
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
    March 13, 2012 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: March 13, 2012 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer Amendment Date(s) if applicabl…
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
    October 01, 2019 - Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD Purpose of Review To evaluate the effectiveness and harms of pharmacologic and nonpharmacologic treatments for exacerbations of chronic obstructive pulmonary disease. Key Messages • Antibiotic therapy in…
  16. S123 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
    October 01, 2007 - ORIGINAL ARTICLE Heterogeneity and the Interpretation of Treatment Effect Estimates From Risk Adjustment and Instrumental Variable Methods John M. Brooks, PhD,* and Elizabeth A. Chrischilles, PhD† Objectives: To contrast the interpretations of treatment effect esti- mates using risk adjustment and instrumental vari…
  17. psnet.ahrq.gov/perspective/conversation-withdavid-c-classen-md-ms
    May 01, 2012 - In Conversation With…David C. Classen, MD, MS May 1, 2012  Also Read an Essay Citation Text: In Conversation With…David C. Classen, MD, MS. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 20…
  18. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-14-attach-1.pdf
    January 01, 2011 - ADHD Performance Measurement Set Attention Deficit Hyperactivity Disorder Performance Measurement Set Supported by AHRQ/CHIPRA-PQMP Proposed by the ADHD Expert Work Group (listed in Appendix A) In collaboration with the Pediatric Measurement Center of Excellence (PMCo…
  19. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-14-attachment-1.pdf
    January 01, 2011 - Measure 1, Section 14, Attachment 1 Attention Deficit Hyperactivity Disorder Performance Measurement Set Supported by AHRQ/CHIPRA-PQMP Proposed by the ADHD Expert Work Group (listed in Appendix A) In collaboration with the Pediatric Measurement Center of Excellence (P…
  20. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfmethods.pdf
    January 01, 2020 - Integrating Evidence-Based Clinical and Community Strategies to Improve Health I S J L C A I U c c ( h t u e u t U o r a F o s R C M P H l A o A C P s t 2 Review and Special Articles ntegrating Evidence-Based Clinical and Community trategies to Improve Health udith K. Ockene, PhD, MEd, Elizabeth A. Edgerton…